PharmacoEconomics · 1997 · 11 citations · 0 references
PharmacyPharmacoeconomicsPharmacotherapyCardiovascular PharmacotherapyCost-effectiveness AnalysisPharmacoeconomic ModelingCardiovascular Disease PreventionCholesterol MetabolismCost-effectiveness ModelingDyslipidemia ManagementLipid-lowering TherapyPharmacoeconomic EvaluationCholesterol Lowering PreventionCost-effectivenessHmg-coa Reductase InhibitorsLdl Cholesterol LoweringLow-density Lipoprotein Cholesterol LoweringLow-density Lipoprotein Cholesterol Reduction